PACIFICHEALTH LABORATORIES INC Financials

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-...
Click here to read the whole Article (external link)

PACIFICHEALTH LABORATORIES INC Files SEC form 10-Q, Quarterly Report

Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS In this Report on Form 10-Q, the terms the "Company," "we", "us," and "our" refer to PacificHealth Laboratories, Inc. (a) Introduction PacificHealth Laboratories (hereinafter referred to as the "Company", "us", or "we") is a leading nutrition company that was incorporated in the State of Delaware in April 1995. We focus on the development, marketing and selling of patented premium nutrition tools that enable our consumers to enhance their health and improve their performance. Our principal area of focus is exercise performance and recovery, including optimal weight management. Our products can be marketed without prior Food and Drug Administration ("FDA") approval under current regulatory guidelines. We are evolving into a more consumer oriented, brand driven company that derives value from its own brands based on our science-based nutrition technology. We have previously been a pioneer in the development of patented nutritional products that activate biochemical pathways to enhance muscle endurance and additionally the specific peptides involved in appetite regulation. Today, we employ multiple strategies for the commercialization of our technologies, but we are placing increasing emphasis on the creation of brands. We are also decreasing our emphasis on further research and development. The ongoing development of our new strategy strategic and financial turnaround is evidenced by some of the key measures of 2009. For the quarter ended September 30, 2009 as shown below, sales and marketing expenses are up $224,876, or 65%, from the same period in 2008. A significant portion of this increase is related to the creation of a new national sales representation organization. Likewise, for the quarter ended September 30, 2009, general and administrative expenses have decreased $106,838, or 12%, which...
Click here to read the whole Article (external link)

PacificHealth Laboratories Reports 9% Third Quarter 2009 Revenue Growth

PACIFICHEALTH LABORATORIES, INC. STATEMENTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2009 AND 2008 (UNAUDITED)         Three Months Nine Months Ended September 30, Ended September 30,   2009     2008     2009     2008     Revenues: Net product sales $ 2,376,291 $ ...
Click here to read the whole Article (external link)

PacificHealth Laboratories, Inc. Schedules Third Quarter 2009 Financial Results Conference Call for October 28, 2009 at 4:00 P.M. ET

MATAWAN, N.J.--(BUSINESS WIRE)--PacificHealth Laboratories, Inc. (OTCBB: PHLI - News), a leading sports nutrition company, today announced plans to release third quarter fiscal year 2009 financial results on Wednesday, October 28, 2009. Jason Ash, President and Chief Executive Officer and Stephen Kuchen, Chief Financial Officer, will host a conference call at 4:00 p.m. Eastern on Wednesday, October 28, 2009 to discuss the Company's third quarter fiscal 2009 financial results and ongoing marketing initiatives. Shareholders and other interested parties may participate in the conference call by dialing (877) 407-9210 (domestic) or (201) 689-8049 (international) a few minutes before the start of the call. No pass code is required. A simultaneous webcast will be available via the Company’s website at ...
Click here to read the whole Article (external link)

PacificHealth Laboratories to Present at the Accredited Members Small Cap/Micro Cap Conference

MATAWAN, N.J.--(BUSINESS WIRE)--PacificHealth Laboratories, Inc. (OTCBB: PHLI - News), a leading sports nutrition company, announced today that it will present at the Accredited Members Small Cap/Micro Cap Conference on Tuesday, September 29, 2009 at 11:25 ET at The Broadmoor Hotel, Colorado Springs, CO. There will be fifteen companies presenting at the conference over a two day period, and attendance by institutional and private investors is by invitation only. Accredited Members grew out of Edgewater Research, one of the most recognized and successful microcap research firms in the industry. Jason Ash, President and CEO of PacificHealth Laboratories, Inc., will address the conference at 11:25 am ET to discuss the Company's business strategy and financial performance. The Company’s presentation will be available on its website (www.pacifichealthlabs.com) on September 29, 2009.About PacificHealth Laboratories:PacificHealth Laboratories, Inc. is an innovative and leading sports nutrition company that focuses on marketing, developi...
Click here to read the whole Article (external link)

PacificHealth Labs Debuts New Sports Nutrition and Weight Management Products at Interbike

Copyright © 2009 Yahoo! All rights reserved. Privacy Policy - Terms of Service - Copyright Policy - Report Problems Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quote data delayed 15 minutes for Nasdaq, NYSE and Amex. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Yahoo! is not an investment adviser and does not provide, endorse or review any information or data contained herein....
Click here to read the whole Article (external link)

PacificHealth Laboratories Announces Three FORZE GPS Marketing Initiatives

MATAWAN, N.J.--(BUSINESS WIRE)--PacificHealth Laboratories, Inc. (OTCBB: PHLI - News), a leading sports nutrition company, is pleased to announce three marketing initiatives for FORZE GPS™ bars and drinks, the first scientifically proven appetite control tools created specifically for athletes. The first initiative involves GNC, the largest specialty retailer of nutritional products, which will partner with the Company to conduct a targeted customer email campaign involving extensive couponing and advertising. GNC, which in August began selling the full line of FORZE GPS products nationwide in approximately 1500 of its top performing stores, expects to reach over 250,000 opted-in consumers during this marketing campaign.th, San Jose on October 4th, San Antonio on November 15th, and Las Vegas on December 6th. Each marathon is preceded by a two-day health & fitness expo prior to the event, where all participants must visit to pick up their race packets and goodie bags which contain FORZE GPS bars - - the “Official Bar” of the Rock ‘n’ Roll Marathon series.The third initiative is PHLI's participation in the Interbike International Bicycle Expo (...
Click here to read the whole Article (external link)

PACIFICHEALTH LABORATORIES INC Files SEC form 10-Q, Quarterly Report

Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS In this Report on Form 10-Q, the terms the "Company," "we", "us," and "our" refer to PacificHealth Laboratories, Inc. (a) Introduction PacificHealth Laboratories (hereinafter referred to as the "Company", "us", or "we") is a leading nutrition company that was incorporated in the State of Delaware in April 1995. We focus on the development, marketing and selling of patented premium nutrition tools that enable our consumers to enhance their health and improve their performance. Our principal areas of focus are sports performance and recovery, including optimal weight management. Our products can be marketed without prior Food and Drug Administration ("FDA") approval under current regulatory guidelines. Going forward, we expect to become a more commercially oriented consumer driven company that derives performance from its brands and science-based nutrition technology. We are a pioneer in the development of patented protein-based nutritional products that activate biochemical pathways to enhance muscle endurance and additionally the specific peptides involved in appetite regulation. We employ multiple strategies for the commercialization of our technologies including: 1) launching a brand via highly targeted consumer channels, 2) licensing the technology to a major food or drug company, or 3) a combination of both 1 and 2. Sports Performance Our research into factors influencing exercise performance, muscle endurance, and recovery has led to the development and commercialization of a new generation of sports and recovery drinks. The key to our technology is the specific ratio in which protein is combined with carbohydrates. We have received two patents on this technology and over 17 studies have been published demonstrating that products based on this technology can extend enduranc...
Click here to read the whole Article (external link)

PACIFICHEALTH LABORATORIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements an

Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers. (e) On June 24, 2009, with the recommendation and approval of the Compensation Committee of the Board of Directors, PacificHealth Laboratories, Inc. (the "Company") entered into Amendment No. 2 (the "Amendment") to the Employment Agreement dated January 3, 2008, as amended August 5, 2008, with Jason Ash, President and Chief Executive Officer of the Company. The Employment Agreement's initial term began on January 3, 2008 and ends on December 31, 2009. Pursuant to the Amendment, the Company extended the initial term to December 31, 2012. In addition, pursuant to the Amendment, the Employment Agreement was amended to delete the requirement for annual increases at least equal to the change in the consumer price index. The Agreement will continue to provide for annual salary adjustments with a market increase consistent with the position, Company performance, and responsibilities of Mr. Ash. The Employment Agreement provided Mr. Ash with a relocation/travel/car stipend in the first two years of his employment. In the Amendment, in lieu of this, the Company has agreed to pay Mr. Ash a one-time stipend in the amount of $50,000 in the event all of the following occur: (a) Mr. Ash terminates his employment under the Employment Agreement for Good Reason (as defined in the Employment Agreement), or the Company terminates his employment under the Employment Agreement without cause; (b) As a result of such termination, Mr. Ash's H1B visa is terminated and he is required to leave the United States upon 30 days (or less) notice; and (c) Mr. Ash in fact does leave the United States for the above reasons without having obtained a new visa. On June 24, 2009, pursuant to Mr. Ash's Employment Agreement, as amended, the Board of Directors approved the issuance of additional options to purc...
Click here to read the whole Article (external link)

PACIFICHEALTH LABORATORIES INC Files SEC form 8-K, Unregistered Sale of Equity Securities

Show all filings for PACIFICHEALTH LABORATORIES INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for PACIFICHEALTH LABORATORIES INC 25-Jun-2009Unregistered Sale of Equity Securities Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for inform...
Click here to read the whole Article (external link)